Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision tag was updated to v3.5.4, reflecting a minor update to the page’s versioning.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a background update to the site tooling rather than any change to the clinical trial information.SummaryDifference0.0%

- Check46 days agoChange Detected- Updated the revision tag from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check90 days agoChange Detected- Revision: v3.4.3 was applied to the page, replacing the previous v3.4.2.SummaryDifference0.0%

- Check111 days agoChange DetectedAdded the study condition 'Gastric cancer' and a new resource link to the Genetic and Rare Diseases Information Center; Updated the page revision to v3.4.2, replacing v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.